Legal experts say the proposed cuts violate federal law and are unlikely to survive a legal challenge by states.

Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that ...

A court battle is set to resume Friday over the Trump administration’s drastic cuts in medical research funding that many ...

Faculty members share insights, expertise on the ramifications of a decline in federal support for science and research ...